Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
The company is planning to expand its plant capacity in in Vapi
Alembic Pharmaceuticals receives 11 USFDA product approval during Q1 FY2025
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
Laurus Labs receives EIR from USFDA for API facilities
The facility was inspected from May 7 to May 17, 2024
Approval based on DUO-E trial results, which showed Imfinzi reduced the risk of disease progression or death by 58% vs. chemotherapy
There was no observation related to data integrity reported
Glenmark's current portfolio consists of 197 products authorized for distribution in the U.S. marketplace
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
Subscribe To Our Newsletter & Stay Updated
